Multiple Myeloma Rounds ®
We are excited to announce the formation of the Multiple Myeloma Rounds® !
Please Join us at one of these Free CME/CE Accredited Dinner Programs in your area!
In 2016, Dr. Agne Paner and her colleagues at several institutions in the Chicago area joined together to form the Chicago Multiple Myeloma Rounds Committee. Their collaborative effort led to the implementation of four Multiple Myeloma Rounds programs that were held in the Chicago area in 2016.
As a result of the success of the Chicago Multiple Myeloma Rounds, the Committee decided to expand the program to other multiple myeloma communities around the country.
We are pleased that the Multiple Myeloma Rounds program has now grown to include a Committee of 36 multiple myeloma specialists from 24 different institutions who will be implementing the Multiple Myeloma Rounds program in 5 cities across the country!
This program will continue to provide a forum for local healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their multiple myeloma patients.
The Multiple Myeloma Rounds provides an opportunity for participants to exchange information, network with their colleagues, share best practices and learn the latest information on new therapies and advances in the management of multiple myeloma through interactive case studies presented by experts in the local area.
Please join us at one of the upcoming events!
The Multiple Myeloma Rounds Program Chairs and Committee Members
Chicago Multiple Myeloma Rounds Founding Chair and CME Course Director:
Agne Paner, MD Rush University
Chicago Multiple Myeloma Rounds Regional Chairpersons
(A complete list of all Committee Members can be found on tab at top of page)
Atlanta: Ajay K. Nooka, MD, MPH, FACP Winship Cancer Institute Emory University
Chicago: Agne Paner, MD Rush University
Florida: Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD Moffitt Cancer Center
NYC/NJ: Ola Landgren, MD and Neha S. Korde, MD Memorial Sloan Kettering Cancer Center
Seattle: William Bensinger, MD Swedish Cancer Institute
In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.
Rush University Medical Center designates this Live Activity for a maximum of two (2) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this live activity for two (2) Continuing Education credits. This activity will fulfill Category 2 contact hour requirements for pharmacology for ANCC certified advanced practice nurses.
This program is approved for 2.0 hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
There is no fee for participating in this activity.
1. Distinguish among the biologic and molecular mechanisms involved in the pathology of MM as it relates to therapeutic targets and treatment selection
2. Appraise conventional, newly approved, and emerging therapies thathave the potential to enhance clinical outcomes
3. Identify disease- and therapy-associated adverse events and utilize evidence-based management strategies
4. Devise optimal evidence-based strategies for individualized treatment
5. Identify limitations and controversies in the standard of care treatment in MM, and how these pertain to individual patient management
Multiple Myeloma Rounds®: is supported by an educational grant from AbbVie Inc., Amgen, Celgene Corporation, Incyte Corporation, Janssen Biotech, Inc., and Merck
Atlanta Multiple Myeloma Rounds Committee:
Ajay Nooka, MD, MPH, FACP (Program Chair)
Cancer Treatment Centers of America:
Mary Ninan, MD
Georgia Cancer Specialists:
Kathleen Lambert, MD
Lynn Zemsky, MD
Northwest Georgia Oncology Centers:
Michael B. Andrews, MD
Piedmont Cancer Institute:
Jonathan Bender, MD
Suburban Hematology-Oncology Associates:
Praveen Sivakumaran, MD
The Blood and Marrow Transplant Group of Georgia
Asad Bashey, MD, PhD
Scott R. Solomon, MD
Melhem Sohl, MD
Kent Holland, MD
Date:Wednesday, February 6, 2019
Location: The Ivy Room
12 East Ohio St, Chicago, IL 60611
Chicago Multiple Myeloma Rounds Committee
Loyola University Medical Center:
Kevin Barton, MD
Patrick Hagen, MD
Advocate Lutheran General Hospital:
Tulio Rodriguez, MD
Medical College of Wisconsin:
Binod Dhakal, MD
Parameswaran Hari, MD
Rush University Medical Center:
Agne Paner, MD, (Program Chair) and Parameswaran Venugopal, MD
John H. Stroger, Jr Hospital of Cook County:
David Sumoza, MD
University of Illinois at Chicago Medical Center:
Pritesh Patel, MD
University of Chicago Medical Center:
Michael Bishop, MD
Florida Multiple Myeloma Rounds Committee
Moffitt Cancer Center:
Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD
NYC/NJ Multiple Myeloma Rounds Committee
Memorial Sloan Kettering Cancer Center:
Ola Landgren, MD (Program Chair)
Columbia University Medical Center:
Suzanne Lentzsch, MD
Hackensack Medical Center:
David Siegel, MD, Noa Biran, MD, David Vesole, MD
Memorial Sloan Kettering Cancer Center:
Neha S. Korde, MD
Mount Sinai Hospital:
Sundar Jagannath, MD, Joshua Richter, MD, Deepu Madduri, MD
Weill Cornell Medical Center:
Ruben Niesvizky, MD, Roger N. Pearse, MD, Adriana Rossi, MD, Cara Rosenbaum, MD
Seattle Multiple Myeloma Rounds Committee
Swedish Cancer Institute
William Bensinger, MD (CO-CHAIR)
Seattle Cancer Care Alliance/University of Washington
Edward Libby, MD (CO-CHAIR)
Fred Hutchinson Cancer Center:
Damian Green, MD
Swedish Cancer Institute:
Ami Batchelder, PA-C
VA Puget Sound Health Care system/University of Washington Medical Center
Thomas Chauncey, MD
The Multiple Myeloma Rounds program is proudly endorsed by:
The Leukemia Foundation
The Amyloidosis Foundation
If your company is interested in exhibiting at any of these events, please contact us at:
E-mail: [email protected]